Healthcare cost reduction

These realities of the current state of healthcare have caused healthcare policy-makers to use several methods to regulate the supply and demand of health services and thereby control the cost of those serv ices. Attempts to reduce the supply of services include a reduction in the reimbursement for services or a reduction in the number of physicians and specialists. These approaches may contain the growth of healthcare costs but a reduction in the capacity of the healthcare system also limits the patient access to services, resulting in longer waits for non-emergency services. Attempts to reduce the demand for services include ... 

The general mission of JCTLM was agreed to be improvement in quality of healthcare with reduction in costs for governments and IVD industry through promotion of reference examination systems allowing traceability of examination results with improved comparability. 

Compliance is a big problem in medical care. Most patients do not like to take medications or fail to take than as instructed. Drags with sustained release can remedy some of these problems. Once daily dosage with sustained action is likely to improve the compliance rate to 80% when compared with 40% for three or four times a day. Some of the novel delivery methods such as transdermal or buccal are preferred by most patients to oral intake or injections. Lack of compliance is responsible for a significant number of hospital admissions in the USA (as high as 10% in some estimates). Overall cost of noncompliance in the USA was more than 100 billion in 2006. Improvement of compliance can lead to significant reductions in healthcare costs. 

Reduction of healthcare costs. Lack of compliance is a considerable burden on the healthcare systems because of inaeased hospitalizations. Improvement of compliance by appropriate drug dehvery systems reduces the cost of healthcare. An appropriate delivery system also reduces the amount of drug used and thus reduces the costs. 

The development of NICE in the UK is being watched keenly throughout the world to see if this organisation will have an indirect effect on reducing healthcare costs. There has been a perceived reduction in competitiveness in the UK pharmaceutical industry over the past few years, and to this end the ABPI and the Department of Health (DoH) established the Pharmaceutical Industry Competitiveness Task Force in April 2000. The first reports of the Task Force have established of the DoH Research Governance Framework, as well as further regulatory improvements complying with the EU GCP Directive. 

Albright PS, Livingstone S, Keegan DL (1996). Reduction of healthcare resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy a retrospective analysis using the Saskatchewan Health Linkable Databases. Clin Drug Invest 11,289-99. 

Reduction of the cost of healthcare services through sharing critical personal health information in a near real-time basis (government... 

---